A lung cancer researcher describes her journey toward a career in science at Novartis.

A global survey revealed major disconnects in communication, disease awareness and expectations between patients and physicians.

Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success

Three-dimensional clusters of human neurons could allow scientists to watch neurological diseases develop in the lab.

At Novartis, we are constantly pushing the limits of science to develop and deliver transformative medicines that fight disease and help people live life on their terms. 

Novartis researchers aim to improve the lives of patients with osteoarthritis.

Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to address high death rates from stroke and heart disease.

Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.